Portal de Periódicos da CAPES

Are people who inject performance and image‐enhancing drugs an increasing population of N eedle and S yringe P rogram attendees?

2012; Wiley; Volume: 32; Issue: 2 Linguagem: Inglês

10.1111/j.1465-3362.2012.00499.x

1465-3362

Jenny Iversen, Libby Topp, Handan Wand, Lisa Maher,

Hepatitis B Virus Studies

Drug and Alcohol ReviewVolume 32, Issue 2 p. 205-207 Brief Report Are people who inject performance and image-enhancing drugs an increasing population of Needle and Syringe Program attendees? Jenny Iversen, Corresponding Author Jenny Iversen Viral Hepatitis Epidemiology and Prevention Program, The Kirby Institute, The University of New South Wales, Sydney, AustraliaJenny Iversen BAppSci, PWID/NSP Surveillance Coordinator, Libby Topp PhD, Manager, Handan Wand PhD, Senior Lecturer, Lisa Maher PhD, Program Head. Correspondence to Ms Jenny Iversen, The Kirby Institute, The University of New South Wales, Sydney, NSW 2052, Australia. Tel: +61 (0)2 9385 0900; Fax: +61 (0)2 9385 0920; E-mail: [email protected]Search for more papers by this authorLibby Topp, Libby Topp Research Strategy Unit, Cancer Council New South Wales, Sydney, AustraliaSearch for more papers by this authorHandan Wand, Handan Wand Biostatistics and Databases Program, The Kirby Institute, The University of New South Wales, Sydney, AustraliaSearch for more papers by this authorLisa Maher, Lisa Maher Viral Hepatitis Epidemiology and Prevention Program, The Kirby Institute, The University of New South Wales, Sydney, AustraliaSearch for more papers by this author Jenny Iversen, Corresponding Author Jenny Iversen Viral Hepatitis Epidemiology and Prevention Program, The Kirby Institute, The University of New South Wales, Sydney, AustraliaJenny Iversen BAppSci, PWID/NSP Surveillance Coordinator, Libby Topp PhD, Manager, Handan Wand PhD, Senior Lecturer, Lisa Maher PhD, Program Head. Correspondence to Ms Jenny Iversen, The Kirby Institute, The University of New South Wales, Sydney, NSW 2052, Australia. Tel: +61 (0)2 9385 0900; Fax: +61 (0)2 9385 0920; E-mail: [email protected]Search for more papers by this authorLibby Topp, Libby Topp Research Strategy Unit, Cancer Council New South Wales, Sydney, AustraliaSearch for more papers by this authorHandan Wand, Handan Wand Biostatistics and Databases Program, The Kirby Institute, The University of New South Wales, Sydney, AustraliaSearch for more papers by this authorLisa Maher, Lisa Maher Viral Hepatitis Epidemiology and Prevention Program, The Kirby Institute, The University of New South Wales, Sydney, AustraliaSearch for more papers by this author First published: 29 August 2012 https://doi.org/10.1111/j.1465-3362.2012.00499.xCitations: 27Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL References 1 Peters R, Copeland J, Dillon P, Beel A. Patterns and correlates of anabolic-androgenic steroid use. NDARC Technical Report No. 48. Sydney: National Drug and Alcohol Research Centre, 1997. 2 Australian Institute of Health and Welfare. 2010 National Drug Strategy Household Survey Canberra. Available at: http://www.aihw.gov.au/publication-detail/?id=32212254712 (accessed May 2012). 3 Iversen J, Topp L, Maher L. Australian NSP Survey National Data Report 1995–2010. Prevalence of HIV, HCV and injecting and sexual behaviour among NSP attendees. Sydney: Kirby Institute, University of New South Wales, 2011. 4 MacDonald M, Wodak AD, Ali R, et al. HIV prevalence and risk behaviour in needle exchange attenders: a national study. The Collaboration of Australian Needle Exchanges. Med J Aust 1997; 166: 237– 240. 5 Topp L, Iversen J, Wand H, et al. Representativeness of injecting drug users who participate in HIV surveillance: results from Australia's Needle and Syringe Program Survey. J Acquir Immune Defic Syndr 2008; 47: 632– 638. 6 Australian Government. Australian Customs and Border Protection Service, Annual Report 2010–11. Canberra. 2011. Available at: http://www.customs.gov.au/webdata/resources/files/879316AUSCUSwebpdf.pdf (accessed April 2012). 7 Aitken C, Delalande C. A public health initiative for steroid users in Victoria. Aust J Prim Health 2002; 8: 21– 23. 8 Larance B, Degenhardt L, Copeland J, Dillon P. Injecting risk behaviour and related harm among men who use performance- and image-enhancing drugs. Drug Alcohol Rev 2008; 27: 679– 686. 9 Day CA, Topp L, Iversen J, Maher L. Blood-borne virus prevalence and risk among steroid injectors: results from the Australian Needle and Syringe Program Survey. Drug Alcohol Rev 2008; 27: 559– 561. 10 Aitken C, Delalande C, Stanton K. Pumping iron, risking infection? Exposure to hepatitis C, hepatitis B and HIV among anabolic-androgenic steroid injectors in Victoria, Australia. Drug Alcohol Depend 2002; 65: 303– 308. 11 Dunn M. Are anabolic-androgenic steroid users polysubstance users? J Sci Med Sport 2009; 12: e1-2. 12 Dunn M. The non-medical use of steroids in Australia: results from a general population survey. Aust N Z J Public Health 2010; 34: 531– 532. Citing Literature Volume32, Issue2March 2013Pages 205-207 ReferencesRelatedInformation